Drug Type Stem cell therapy |
Synonyms Cellgram |
Target- |
Action- |
Mechanism Cell replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date South Korea (23 Dec 2011), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Myocardial Infarction | South Korea | 23 Dec 2011 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Liver Cirrhosis | Phase 3 | South Korea | 26 Feb 2021 | |
Spinal Cord Injuries | Phase 3 | South Korea | 29 Aug 2008 | |
Stroke | Phase 3 | South Korea | 24 Jan 2008 | |
Erectile Dysfunction | Phase 2 | United States | 19 Oct 2020 | |
Respiratory Distress Syndrome, Adult | Phase 2 | South Korea | 25 Jan 2014 | |
Renal transplant rejection | Phase 2 | South Korea | 07 Dec 2007 | |
Parkinson Disease | Phase 2 | South Korea | 29 Dec 2006 | |
Brain Injuries | Clinical | South Korea | - | |
Cerebral Hemorrhage | Clinical | South Korea | - | |
Solid tumor | Clinical | South Korea | - |